Free Trial

National Health Investors (NYSE:NHI) Stock Price Target Lowered at Wells Fargo & Company

National Health Investors logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Wells Fargo cut its price target on National Health Investors from $68 to $65 while maintaining an “equal weight” rating; the new target implies 3.89% upside from the current price.
  • Analyst opinion is mixed: the stock has a MarketBeat consensus “Moderate Buy” rating and an average $79.11 target, though Bank of America recently downgraded it to “underperform.”
  • NHI shares opened at $62.56, near the reported 12-month low of $62.70. The REIT reported quarterly EPS of $11.47, beating the $1.18 consensus estimate, and revenue of $113.48 million versus $68.53 million expected.
  • Five stocks to consider instead of National Health Investors.

National Health Investors (NYSE:NHI - Get Free Report) had its price target cut by research analysts at Wells Fargo & Company from $68.00 to $65.00 in a report released on Monday, Benzinga reports. The firm presently has an "equal weight" rating on the real estate investment trust's stock. Wells Fargo & Company's price objective suggests a potential upside of 3.89% from the stock's current price.

NHI has been the topic of several other research reports. Huntington initiated coverage on shares of National Health Investors in a research report on Monday, November 9th. They set a "strong-buy" rating on the stock. National Bank Financial set a $79.00 target price on National Health Investors in a research note on Wednesday, September 9th. Zacks Research raised National Health Investors from a "strong sell" rating to a "hold" rating in a research note on Tuesday, September 29th. Truist Financial decreased their price target on National Health Investors from $81.00 to $80.00 and set a "buy" rating on the stock in a research note on Wednesday, September 2nd. Finally, Bank of America lowered National Health Investors from a "buy" rating to an "underperform" rating and decreased their price target for the company from $86.00 to $67.00 in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, National Health Investors currently has a consensus rating of "Moderate Buy" and an average target price of $79.11.

Check Out Our Latest Stock Analysis on National Health Investors

National Health Investors Stock Down 0.6%

NHI stock opened at $62.56 on Monday. The firm's fifty day simple moving average is $67.30 and its 200-day simple moving average is $75.85. The company has a market capitalization of $3.07 billion, a P/E ratio of 4.45, a price-to-earnings-growth ratio of 4.05 and a beta of 0.51. The company has a debt-to-equity ratio of 0.50, a current ratio of 13.59 and a quick ratio of 13.59. National Health Investors has a 12 month low of $62.70 and a 12 month high of $91.38.

National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings data on Monday, November 9th. The real estate investment trust reported $11.47 earnings per share for the quarter, topping analysts' consensus estimates of $1.18 by $10.29. The firm had revenue of $113.48 million for the quarter, compared to analyst estimates of $68.53 million. National Health Investors had a net margin of 152.82% and a return on equity of 41.41%. As a group, equities research analysts forecast that National Health Investors will post 4.72 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. BlackRock Inc. purchased a new position in National Health Investors in the 2nd quarter valued at approximately $665,997,000. Bank of New York Mellon Corp purchased a new stake in shares of National Health Investors during the second quarter worth $122,509,000. Bank of America Corp DE increased its position in shares of National Health Investors by 20.0% during the first quarter. Bank of America Corp DE now owns 992,802 shares of the real estate investment trust's stock worth $80,278,000 after acquiring an additional 165,467 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of National Health Investors by 2.7% in the first quarter. Dimensional Fund Advisors LP now owns 686,249 shares of the real estate investment trust's stock valued at $55,493,000 after acquiring an additional 18,164 shares in the last quarter. Finally, Legal & General Group Plc acquired a new stake in shares of National Health Investors in the second quarter valued at $21,745,000. Hedge funds and other institutional investors own 62.51% of the company's stock.

National Health Investors Company Profile

(Get Free Report)

National Health Investors, Inc. NYSE: NHI is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee. NHI's portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans. The company serves markets across the United States.

Featured Articles

Analyst Recommendations for National Health Investors (NYSE:NHI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines